To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene ZNF430andZNF714TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
237 supporting clones for gene ZNF430andZNF714 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BC050468 Testis, embryonal carcinoma .a 1 to 2654 1 to 2655 E209N L210E N211L Q212N C213Q ... tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2655/2655
(100 %)
6 diff
(99.8 %id)
DB452623 testis .a 368 to 841 1 to 477     Submitted on the opposite strand 477/477
(100 %)
1 diff
(99.8 %id)
DA735183   .a 626 to 1440 2 to 818   capped   817/817
(100 %)
10 diff
(98.8 %id)
BX409815 brain, fetal brain .a 2006 to 2836 12 to 846   tiling clone,   835/849
(98 %)
20 diff
(97.7 %id)
AW969194   .a 2745 to 3235 1 to 492   tiling clone,   492/494
(99 %)
5 diff
(99.0 %id)
BF212451 bone marrow, from chronic myelogenous leukemia .a 2931 to 3556 1 to 618   tiling clone,   618/628
(98 %)
12 diff
(98.1 %id)
CF456751 peripheral nervous system .a 3081 to 3841 1 to 755       755/755
(100 %)
13 diff
(98.3 %id)
AW802198 uterus .a 3106 to 3385 304 to 25       280/313
(89 %)
0 diff
(100 %id)
AW802138 uterus .a 3110 to 3385 285 to 10   tiling clone,   276/285
(96 %)
0 diff
(100 %id)
AW802162 uterus .a 3110 to 3381 282 to 11       272/282
(96 %)
0 diff
(100 %id)
BG285927 bladder, transitional cell papilloma, cell line .a 3149 to 3869 1 to 711       711/907
(78 %)
26 diff
(97.2 %id)
BG178551 adenocarcinoma, cell line, Prostate .a 3441 to 4217 1 to 767   tiling clone,   767/877
(87 %)
27 diff
(97.0 %id)
AA310210   .a 3452 to 3816 1 to 363       363/363
(100 %)
1 diff
(99.8 %id)
N64174 multiple sclerosis lesions .a 3479 to 3976 1 to 513       513/513
(100 %)
22 diff
(95.8 %id)
BX329607 Neuroblastoma Cot 25-normalized .a 3576 to 4296 734 to 9       726/896
(81 %)
0 diff
(100 %id)
AA452421   .a 3631 to 4066 1 to 436       436/436
(100 %)
4 diff
(99.1 %id)
BX413309 brain, fetal brain .a 3635 to 4248 621 to 4   tiling clone,   618/837
(73 %)
0 diff
(100 %id)
BX101999 placenta .a 3655 to 4315 1 to 663   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 663/663
(100 %)
3 diff
(99.6 %id)
AW023448 cochlea, ear .a 3664 to 4132 8 to 475       468/475
(98 %)
6 diff
(98.8 %id)
BQ024987 placenta .a 3664 to 4315 670 to 19   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 652/652
(100 %)
3 diff
(99.6 %id)
R74564 placenta .a 3687 to 4060 1 to 378       378/378
(100 %)
8 diff
(97.9 %id)
H13735 placenta .a 3687 to 4012 1 to 338       338/359
(94 %)
14 diff
(96.2 %id)
DB367385   .a 3769 to 4315 548 to 1       548/551
(99 %)
16 diff
(97.1 %id)
AA521152 germinal center B cell .a 3773 to 4315 565 to 25   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 541/543
(99 %)
13 diff
(97.7 %id)
AI366913 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .a 3836 to 4316 488 to 8       481/488
(98 %)
0 diff
(100 %id)
AA814750 germinal center B cell .a 3892 to 4315 437 to 14   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 424/424
(100 %)
1 diff
(99.8 %id)
DB518063 testis .a 3898 to 4317 1 to 420   tiling clone, Submitted on the opposite strand 420/437
(96 %)
2 diff
(99.6 %id)
AI561020 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .a 3902 to 4317 418 to 3       416/418
(99 %)
0 diff
(100 %id)
AA993846   .a 3908 to 4241 334 to 1     Submitted on the opposite strand 334/334
(100 %)
1 diff
(99.8 %id)
AI914410 pooled .a 3917 to 4315 415 to 17   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 399/399
(100 %)
2 diff
(99.5 %id)
AW044151 pooled .a 3922 to 4316 403 to 9       395/403
(98 %)
0 diff
(100 %id)
AA765698 germinal center B cell .a 3941 to 4315 388 to 14   AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 375/375
(100 %)
1 diff
(99.8 %id)
DB510421 testis .a 3959 to 4315 1 to 357     Submitted on the opposite strand 357/357
(100 %)
1 diff
(99.8 %id)
AA746881 alveolar rhabdomyosarcoma .a 4030 to 4316 294 to 8       287/294
(97 %)
0 diff
(100 %id)
BQ022955 placenta .a 4043 to 4308 290 to 26   AAA   265/272
(97 %)
0 diff
(100 %id)
FN059404 breast carcinoma .a 4065 to 4187 1 to 123       123/123
(100 %)
0 diff
(100 %id)
R74465 placenta .a 4078 to 4309 234 to 1       234/234
(100 %)
3 diff
(98.8 %id)
N64175 multiple sclerosis lesions .a 4104 to 4315 213 to 1       213/215
(99 %)
2 diff
(99.1 %id)
DA556058   .b 1 to 560 10 to 569   capped   568/568
(100 %)
3 diff
(99.5 %id)
DA483745 brain .b 1 to 522 7 to 528   capped   527/527
(100 %)
2 diff
(99.7 %id)
DA587441 lung .b 1 to 589 7 to 595   capped   594/594
(100 %)
2 diff
(99.7 %id)
DB102162 thymus .b 1 to 544 7 to 550   tiling clone, capped   549/549
(100 %)
0 diff
(100 %id)
DA750594   .b 1 to 565 6 to 570   capped   569/569
(100 %)
2 diff
(99.7 %id)
DA788358 brain .b 1 to 570 4 to 573   capped   572/572
(100 %)
2 diff
(99.7 %id)
DA749709   .b 1 to 504 3 to 506   capped   505/505
(100 %)
2 diff
(99.7 %id)
DA944534 Spleen .b 1 to 547 3 to 549   capped   548/548
(100 %)
1 diff
(99.9 %id)
DB104911 thymus .b 1 to 560 3 to 562   capped   561/561
(100 %)
1 diff
(99.9 %id)
DA629052 Kidney .b 1 to 586 2 to 587   capped   586/586
(100 %)
3 diff
(99.5 %id)
DN990862 brain, whole brain .b 6 to 735 1 to 729       729/729
(100 %)
9 diff
(98.8 %id)
AX721141   .b 14 to 900 1 to 887       887/892
(99 %)
3 diff
(99.7 %id)
AW963798   .b 33 to 654 1 to 622       622/624
(99 %)
16 diff
(97.5 %id)
AY269787   .b 33 to 2681 1 to 2649 K150R tiling clone,   2649/2649
(100 %)
3 diff
(99.9 %id)
CN258632 embryonic stem cells, cell lines H1, H7, andH9 .b 68 to 615 1 to 548       548/548
(100 %)
1 diff
(99.9 %id)
AK023721 placenta .b 146 to 2280 165 to 2298 K150R E293N C294V G295A T297P ... available from FLJ,   2298/2298
(100 %)
5 diff
(99.8 %id)
AK290475 brain .b 146 to 2280 185 to 2319 L24P tiling clone,   2319/2319
(100 %)
2 diff
(100.0 %id)
DA495838 brain .b 146 to 539 185 to 579   capped   578/578
(100 %)
3 diff
(99.5 %id)
NM_025189.3   .b 146 to 3880 185 to 3919 exact RefSeq,   3919/3919
(100 %)
0 diff
(100 %id)
AU139909 placenta .b 146 to 499 165 to 519   capped   518/518
(100 %)
3 diff
(99.5 %id)
DA941394 Spleen .b 146 to 504 175 to 533   capped   532/532
(100 %)
1 diff
(99.9 %id)
AU158222 placenta .b 1801 to 2280 478 to 1       478/479
(99 %)
8 diff
(98.4 %id)
BQ636523 eye, retina .b 2037 to 2681 1 to 645       645/645
(100 %)
1 diff
(99.9 %id)
AV707929 adrenal gland .b 2307 to 2980 1 to 674   tiling clone,   674/676
(99 %)
10 diff
(98.6 %id)
DB507896 testis .b 2722 to 3377 1 to 656   tiling clone, Submitted on the opposite strand 656/656
(100 %)
1 diff
(99.9 %id)
EL950672 eyeball .b 2782 to 3266 1 to 485       485/485
(100 %)
2 diff
(99.6 %id)
BQ638610 eye, retina .b 2807 to 3408 1 to 598       598/598
(100 %)
3 diff
(99.5 %id)
BP351446   .b 2883 to 3233 229 to 580       352/580
(60 %)
6 diff
(99.0 %id)
BQ706964 Spleen .b 2999 to 3377 1 to 379   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 379/379
(100 %)
0 diff
(100 %id)
BQ364298 stomach .b 3261 to 3760 499 to 1   tiling clone,   499/502
(99 %)
6 diff
(98.9 %id)
H65282 liver and spleen .b 3366 to 3762 1 to 409   tiling clone, Submitted on the opposite strand 409/442
(92 %)
28 diff
(93.7 %id)
AA314140 colon .b 3411 to 3847 1 to 437       437/437
(100 %)
0 diff
(100 %id)
AI623759 adenocarcinoma, Pancreas .b 3416 to 3879 469 to 6       464/478
(97 %)
0 diff
(100 %id)
AA768701 germinal center B cell .b 3485 to 3879 423 to 29   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 395/395
(100 %)
3 diff
(99.3 %id)
AI420537 Prostate .b 3530 to 3880 351 to 1   tiling clone,   351/359
(97 %)
0 diff
(100 %id)
DA786911 brain .c 1 to 571 7 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
DA916012 small intestine .c 1 to 529 7 to 535   capped   534/534
(100 %)
1 diff
(99.9 %id)
CR735677 astrocytoma grade IV, cell line, brain .c 1 to 499 40 to 538       501/538
(93 %)
0 diff
(100 %id)
DA288678 corpus callosum .c 1 to 556 3 to 558   capped   557/557
(100 %)
2 diff
(99.7 %id)
BM908927 astrocytoma grade IV, cell line, brain .c 1 to 418 2 to 419       419/1297
(32 %)
5 diff
(99.7 %id)
DA934813 Spleen .c 1 to 573 3 to 575   capped   574/574
(100 %)
2 diff
(99.7 %id)
DB255551 uterus .c 1 to 573 3 to 575   tiling clone, capped   574/574
(100 %)
1 diff
(99.9 %id)
DB442952 testis .c 2 to 619 1 to 618       618/659
(93 %)
14 diff
(97.9 %id)
DA307448 hippocampus .c 24 to 609 2 to 587   capped   586/586
(100 %)
1 diff
(99.9 %id)
BC111776 PCR rescued clones .c 74 to 1924 1 to 1851 exact tiling clone,   1851/1851
(100 %)
1 diff
(100.0 %id)
CD694044 normal nasopharynx .c 146 to 452 203 to 509       488/509
(95 %)
0 diff
(100 %id)
NM_001172671.1   .c 146 to 3877 185 to 3916 exact RefSeq,   3916/3916
(100 %)
0 diff
(100 %id)
AU143734   .c 713 to 1519 2 to 803   capped   802/806
(99 %)
12 diff
(98.6 %id)
AL832422 melanoma (MeWo cell line) .c 1074 to 3876 1 to 2801   tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 2801/2802
(99 %)
3 diff
(99.9 %id)
CT000384 T-Lymphocytes .c 1334 to 2089 1 to 756       756/756
(100 %)
0 diff
(100 %id)
AA309966   .c 1482 to 1920 1 to 439       439/439
(100 %)
3 diff
(99.4 %id)
DA717845   .c 1600 to 2160 2 to 563   capped   562/562
(100 %)
1 diff
(99.9 %id)
DB384876   .c 2816 to 3374 560 to 1       560/563
(99 %)
9 diff
(98.5 %id)
DA026469   .d 1 to 582 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
DB028091 testis .d 1 to 506 2 to 507   tiling clone, capped   506/506
(100 %)
0 diff
(100 %id)
AL834415 brain .d 18 to 2144 1 to 2131 E103N L104E N105L Q106N C107Q ... tiling clone, available from DKFZ, AAA   2131/2656
(80 %)
12 diff
(99.6 %id)
NM_182515.2   .d 18 to 8788 1 to 8774 E103N L104E N105L Q106N C107Q ... RefSeq, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 8774/8774
(100 %)
1 diff
(100.0 %id)
DB136638 thymus .d 49 to 594 2 to 547   capped   546/546
(100 %)
4 diff
(99.3 %id)
AK056006   .d 51 to 2161 1 to 2114 E103N L104E N105L Q106N C107Q ... tiling clone, available from FLJ,   2114/2114
(100 %)
5 diff
(99.8 %id)
DA683577   .d 52 to 448 2 to 398   capped   397/398
(99 %)
2 diff
(99.5 %id)
DB108256 thymus .d 52 to 628 2 to 578   capped   577/577
(100 %)
1 diff
(99.9 %id)
BQ215309 embryonal carcinoma, cell line, testis .d 62 to 692 14 to 649   available from MGC,   636/989
(64 %)
24 diff
(97.6 %id)
CN341037 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 69 to 754 1 to 689       689/689
(100 %)
3 diff
(99.6 %id)
DW427604 Liver .d 545 to 808 12 to 278       267/278
(96 %)
6 diff
(97.9 %id)
DA488450 brain .d 629 to 1191 2 to 568   capped   567/567
(100 %)
2 diff
(99.7 %id)
TI_1959498640   .d 682 to 1832 99 to 1238   tiling clone,   1140/1185
(96 %)
17 diff
(98.6 %id)
BF376299 testis_normal .d 759 to 1193 1 to 436       436/436
(100 %)
14 diff
(96.8 %id)
CN341035 embryonic stem cells, DMSO-treated H9 cellline .d 915 to 1553 1 to 638       638/638
(100 %)
2 diff
(99.7 %id)
CN417582 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 1012 to 1751 13 to 752       740/752
(98 %)
6 diff
(99.3 %id)
TI_1959503105   .d 1072 to 2156 1142 to 65       1078/1284
(83 %)
0 diff
(100 %id)
BU195416 eye, retinoblastoma .d 1077 to 1966 1 to 894       894/895
(99 %)
14 diff
(98.5 %id)
BI093435 cervix .d 1241 to 2045 1 to 808   tiling clone,   808/809
(99 %)
21 diff
(97.5 %id)
BF893169 marrow .d 1364 to 1627 261 to 1     Submitted on the opposite strand 261/265
(98 %)
11 diff
(95.9 %id)
DB322786   .d 1613 to 2161 549 to 1       549/549
(100 %)
1 diff
(99.9 %id)
AW409710.
matches multiple genes
muscle, rhabdomyosarcoma .d 1721 to 2161 463 to 23   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base), also hits gene GPR141andTXNDC3andEPDR1 441/441
(100 %)
2 diff
(99.6 %id)
TI_1959499473   .d 1725 to 1747 1071 to 1092     Submitted on the opposite strand 832/1264
(65 %)
12 diff
(99.1 %id)
AI819525 lymph node, lymphoma, follicular mixed small and largecell .d 1826 to 2167 343 to 1       343/343
(100 %)
3 diff
(99.2 %id)
BE888068 leiomyosarcoma, uterus .d 1828 to 2290 1 to 462       462/897
(51 %)
13 diff
(98.6 %id)
CN271670 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 1841 to 2161 1 to 322   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 322/322
(100 %)
4 diff
(98.8 %id)
BQ440000 eye, retinoblastoma .d 1932 to 2683 11 to 772   tiling clone,   762/909
(83 %)
19 diff
(98.0 %id)
BQ893696 dorsal root ganglia .d 1953 to 2819 1 to 869   tiling clone,   869/869
(100 %)
39 diff
(95.6 %id)
N41598 placenta .d 2039 to 2596 1 to 557   tiling clone,   557/558
(99 %)
11 diff
(98.1 %id)
U52097   .d 2228 to 2476 1 to 253       253/253
(100 %)
11 diff
(95.7 %id)
AW190511 adenocarcinoma, Pancreas .d 2380 to 2793 414 to 1       414/414
(100 %)
0 diff
(100 %id)
AA768770 germinal center B cell .d 2624 to 3054 431 to 1   tiling clone,   431/431
(100 %)
2 diff
(99.6 %id)
CN411811 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 2920 to 3639 1 to 720   tiling clone,   720/720
(100 %)
4 diff
(99.5 %id)
CB960509 Human Placenta, placenta .d 2932 to 3643 18 to 740       723/875
(82 %)
23 diff
(97.4 %id)
BX508031   .d 3187 to 3904 1 to 718   tiling clone,   718/718
(100 %)
8 diff
(98.9 %id)
AA249045   .d 3216 to 3369 1 to 155       155/155
(100 %)
14 diff
(91.0 %id)
EC489028 Prostate .d 3279 to 3391 1 to 115       115/117
(98 %)
5 diff
(95.8 %id)
AK125662 synovial membrane tissue from rheumatioidarthritis .d 3766 to 6861 1 to 3096   tiling clone, available from FLJ,   3096/3096
(100 %)
38 diff
(98.8 %id)
DA995279 synovial membrane tissue from rheumatioidarthritis .d 3767 to 4311 2 to 546   capped   545/545
(100 %)
6 diff
(98.9 %id)
CN412192 embryonic stem cells, cell lines H1, H7, andH9 .d 4563 to 5209 1 to 649   tiling clone,   649/649
(100 %)
3 diff
(99.6 %id)
AK090987 amygdala .d 4568 to 6861 1 to 2294   tiling clone, available from FLJ,   2294/2294
(100 %)
33 diff
(98.6 %id)
AX746719   .d 4568 to 6861 1 to 2294       2294/2294
(100 %)
33 diff
(98.6 %id)
DA167148 amygdala .d 4569 to 5063 2 to 496   capped   495/495
(100 %)
4 diff
(99.2 %id)
BF669571 brain, primitive neuroectoderm .d 4716 to 5340 1 to 614       614/841
(73 %)
10 diff
(98.9 %id)
BE160255 head_neck .d 5008 to 5508 72 to 573       502/573
(87 %)
9 diff
(98.5 %id)
DA798558 brain .d 5135 to 5705 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
DB289436 uterus .d 5211 to 5757 2 to 548   capped   547/547
(100 %)
0 diff
(100 %id)
CN273872 embryonic stem cells, DMSO-treated H9 cellline .d 5346 to 6079 1 to 734       734/734
(100 %)
0 diff
(100 %id)
AW888691 nervous_tumor .d 5813 to 5973 162 to 1       162/166
(97 %)
3 diff
(98.2 %id)
AA837464 germinal center B cell .d 5838 to 6267 430 to 1       430/430
(100 %)
2 diff
(99.6 %id)
DB136003 thymus .d 5899 to 6373 2 to 477   capped   476/476
(100 %)
2 diff
(99.6 %id)
BG026759 Bone, osteosarcoma, cell line .d 5966 to 6342 12 to 388   AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 377/388
(97 %)
6 diff
(98.5 %id)
AI364599 serous papillary carcinoma, high grade, 2pooled tumors, uterus .d 6009 to 6343 336 to 2   tiling clone,   335/336
(99 %)
0 diff
(100 %id)
BI014297 lung_tumor .d 6128 to 6561 446 to 9       438/446
(98 %)
0 diff
(100 %id)
DB302454 amygdala .d 6328 to 6861 534 to 1       534/534
(100 %)
20 diff
(96.3 %id)
AA610337 thyroid .d 6387 to 6862 472 to 1   tiling clone,   472/472
(100 %)
16 diff
(96.7 %id)
BI005757 head_normal .d 6439 to 6794 356 to 1   tiling clone,   356/356
(100 %)
7 diff
(98.1 %id)
DB335079 synovial membrane tissue from rheumatioidarthritis .d 6458 to 6861 404 to 1       404/409
(98 %)
10 diff
(97.6 %id)
BX441765 brain, fetal brain .d 6882 to 7662 1 to 781   tiling clone,   781/781
(100 %)
8 diff
(99.0 %id)
BE241840 leukopheresis .d 6961 to 7293 1 to 334   tiling clone,   334/334
(100 %)
13 diff
(96.2 %id)
BU173389 leiomyosarcoma, uterus .d 7045 to 7931 1 to 891   tiling clone,   891/902
(98 %)
17 diff
(98.2 %id)
BM504478 insulinoma, Pancreas .d 7214 to 7701 1 to 488       488/488
(100 %)
9 diff
(98.2 %id)
BX452046 brain, fetal brain .d 7449 to 8413 1 to 965   tiling clone,   965/966
(99 %)
24 diff
(97.6 %id)
BG388618 embryonal carcinoma, cell line, testis .d 7851 to 8616 1 to 754   tiling clone,   754/981
(76 %)
18 diff
(98.2 %id)
AA864532 pooled germ cell tumors .d 8426 to 8788 363 to 1   tiling clone,   363/363
(100 %)
1 diff
(99.8 %id)
BE241413 leukopheresis .d 8467 to 8786 320 to 3       318/320
(99 %)
0 diff
(100 %id)
BE241444 leukopheresis .d 8506 to 8786 280 to 3       278/280
(99 %)
0 diff
(100 %id)
DA181186 amygdala .e 1 to 570 2 to 570   tiling clone, to resequence, capped   569/569
(100 %)
6 diff
(99.0 %id)
DB302927 amygdala .e 1327 to 1802 476 to 1   tiling clone, to resequence,   476/476
(100 %)
0 diff
(100 %id)
BX471470   .f-u 1 to 523 1 to 523   tiling clone,   523/527
(99 %)
4 diff
(99.3 %id)
DA682447 ovary .f-u 231 to 795 2 to 566   capped   565/565
(100 %)
2 diff
(99.7 %id)
BM904065 eye, retinoblastoma .f-u 236 to 1057 1 to 831   tiling clone,   831/963
(86 %)
27 diff
(97.2 %id)
BX504753   .f-u 239 to 873 1 to 635       635/635
(100 %)
0 diff
(100 %id)
BU193870 melanotic melanoma, skin .f-u 334 to 1178 24 to 874   tiling clone,   851/883
(96 %)
11 diff
(98.8 %id)
BX366035 Neuroblastoma Cot 25-normalized .g 1 to 794 1 to 793 R44K K208N S209L Q210S L211W ... tiling clone,   793/799
(99 %)
5 diff
(99.4 %id)
DB501029 hypothalamus .g 33 to 488 1 to 456   tiling clone,   456/456
(100 %)
0 diff
(100 %id)
CN341038 embryonic stem cells, cell lines H1, H7, andH9 .g 43 to 618 13 to 587   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 575/587
(97 %)
6 diff
(99.0 %id)
DB486803 hypothalamus .h 16 to 308 1 to 293   tiling clone,   293/294
(99 %)
19 diff
(93.6 %id)
DB485854 hypothalamus .h 20 to 454 1 to 437       437/437
(100 %)
6 diff
(98.7 %id)
DB487238 hypothalamus .h 20 to 458 1 to 440   tiling clone,   440/440
(100 %)
2 diff
(99.6 %id)
BM755493 stomach .h 54 to 316 1 to 261       261/261
(100 %)
9 diff
(96.6 %id)
BX332832 Neuroblastoma Cot 25-normalized .h 163 to 880 178 to 922 G14V L15F A16S F17P T18S ... tiling clone,   920/922
(99 %)
33 diff
(96.5 %id)
AA309607   .h 584 to 875 1 to 292   tiling clone,   292/292
(100 %)
2 diff
(99.4 %id)
BU598075 mixed (pool of 40 RNAs) .i -10 to 765 1 to 784 S135G I147D T148Y G149R R150A ... tiling clone,   784/854
(91 %)
26 diff
(97.0 %id)
DA083864 cerebellum .i 1 to 384 10 to 393   capped   392/392
(100 %)
2 diff
(99.5 %id)
DA046634 bladder .i 1 to 305 7 to 311   capped   310/310
(100 %)
1 diff
(99.7 %id)
CD703995 normal nasopharynx .i 1 to 365 49 to 414       371/420
(88 %)
3 diff
(99.3 %id)
AA375346 lung .i 32 to 398 1 to 367       367/367
(100 %)
4 diff
(99.0 %id)
AA375490 lung .i 32 to 274 1 to 243       243/243
(100 %)
2 diff
(99.2 %id)
BF967277 brain, hypothalamus .j 1 to 650 2 to 650 A5C A6S G7W A8S A9C ... tiling clone,   650/836
(77 %)
17 diff
(98.0 %id)
BG708988 brain, hypothalamus .j 1 to 764 2 to 770 N101D C161* tiling clone,   770/777
(99 %)
17 diff
(97.9 %id)
BG715857 brain, hypothalamus .j 1 to 711 2 to 719 E69R R70E K71E L72A L73S ... tiling clone, available from MGC,   719/719
(100 %)
18 diff
(97.5 %id)
BC037782 Brain, hypothalamus .j 5 to 2681 6 to 2683   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2678/2678
(100 %)
7 diff
(99.8 %id)
BC022527 Brain, hypothalamus .j 5 to 2681 1 to 2678   tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (16/16 A in genome downstream of last aligned base) 2678/2678
(100 %)
6 diff
(99.8 %id)
DB494176 hypothalamus .j 8 to 487 1 to 480       480/484
(99 %)
2 diff
(99.6 %id)
DB496949 hypothalamus .j 8 to 487 1 to 480       480/484
(99 %)
2 diff
(99.6 %id)
DB499087 hypothalamus .j 8 to 482 1 to 475       475/475
(100 %)
0 diff
(100 %id)
CB069894 Pancreas, Purified pancreatic islet .j 1932 to 2266 1 to 334   fully sequenced,   334/334
(100 %)
3 diff
(99.2 %id)
DB570190 hypothalamus .j 2197 to 2681 1 to 485     Submitted on the opposite strand 485/485
(100 %)
0 diff
(100 %id)
DB567955 hypothalamus .j 2210 to 2681 1 to 472     Submitted on the opposite strand 472/472
(100 %)
1 diff
(99.8 %id)
DB572206 hypothalamus .j 2212 to 2681 1 to 470     Submitted on the opposite strand 470/470
(100 %)
0 diff
(100 %id)
DB556012 hypothalamus .j 2220 to 2681 1 to 463     Submitted on the opposite strand 463/463
(100 %)
7 diff
(98.5 %id)
BX097519 lung, small cell carcinoma .j 2225 to 2695 471 to 1     Submitted on the opposite strand 471/471
(100 %)
0 diff
(100 %id)
DB565213 hypothalamus .j 2228 to 2681 1 to 454     Submitted on the opposite strand 454/454
(100 %)
0 diff
(100 %id)
CB068631 Pancreas, Purified pancreatic islet .j 2236 to 2680 445 to 1   fully sequenced,   445/445
(100 %)
0 diff
(100 %id)
DB554820 hypothalamus .j 2240 to 2681 1 to 445     Submitted on the opposite strand 445/445
(100 %)
7 diff
(98.5 %id)
DB559442 hypothalamus .j 2259 to 2681 1 to 424     Submitted on the opposite strand 424/424
(100 %)
1 diff
(99.8 %id)
DB556582 hypothalamus .j 2261 to 2681 1 to 423     Submitted on the opposite strand 423/423
(100 %)
6 diff
(98.6 %id)
AA911503 lung, small cell carcinoma .j 2281 to 2681 401 to 1       401/401
(100 %)
1 diff
(99.8 %id)
AA907814 lung, small cell carcinoma .j 2284 to 2681 398 to 1       398/398
(100 %)
0 diff
(100 %id)
CN274356 embryonic stem cells, DMSO-treated H9 cellline .k-u 1 to 730 1 to 744 R90L tiling clone,   744/744
(100 %)
10 diff
(98.7 %id)
AW206930   .l 1 to 387 413 to 25 X107D X108G X109V X110S X111L ... tiling clone, AAA Possibly primed on the genome, locally A rich (15/15 A in genome downstream of last aligned base) 374/393
(95 %)
10 diff
(97.5 %id)
DA084487 cerebellum .m 1 to 527 10 to 536 D123N tiling clone, capped   535/535
(100 %)
3 diff
(99.5 %id)
DA519702 brain .n 146 to 515 178 to 549 E117G C118V N119Q G120W A121V ... tiling clone, capped   548/548
(100 %)
4 diff
(99.3 %id)
DA099876 cerebellum .o 1 to 547 9 to 555 exact tiling clone, capped   554/554
(100 %)
3 diff
(99.5 %id)
DA524787 brain .p 1 to 571 2 to 572   tiling clone, capped   571/571
(100 %)
2 diff
(99.7 %id)
DA964544 stomach .p 41 to 593 2 to 554   tiling clone, capped   553/553
(100 %)
0 diff
(100 %id)
BU959448 mixed (pool of 40 RNAs) .p 85 to 731 1 to 659 C94X K95* tiling clone,   659/714
(92 %)
21 diff
(97.1 %id)
CB963957 Blood vessels - aorta, basilar and artery .q 1 to 720 1 to 727 exact tiling clone,   727/750
(96 %)
17 diff
(97.8 %id)
AK127154 caudate nucleus .q 467 to 3025 1 to 2560   tiling clone, available from FLJ,   2560/2560
(100 %)
7 diff
(99.8 %id)
DA265355 caudate nucleus .q 468 to 1021 2 to 558   capped   557/558
(99 %)
9 diff
(98.4 %id)
DA954693 Spleen .q 485 to 948 2 to 465   tiling clone, capped   464/464
(100 %)
3 diff
(99.4 %id)
BQ229156 embryonal carcinoma, cell line, testis .q 1371 to 2138 1 to 775       775/901
(86 %)
22 diff
(97.6 %id)
BX508920   .q 1589 to 2243 1 to 655   tiling clone,   655/655
(100 %)
0 diff
(100 %id)
BG534582 lung .q 2053 to 2620 1 to 569       569/569
(100 %)
3 diff
(99.5 %id)
N30326 placenta .q 2336 to 2789 1 to 461     Submitted on the opposite strand 461/466
(98 %)
21 diff
(95.5 %id)
AW976849   .q 2384 to 3024 646 to 1     Submitted on the opposite strand 646/646
(100 %)
15 diff
(97.7 %id)
DB306815 caudate nucleus .q 2473 to 3025 553 to 1       553/553
(100 %)
0 diff
(100 %id)
N56661 placenta .q 2643 to 3023 387 to 1     Submitted on the opposite strand 387/392
(98 %)
7 diff
(98.3 %id)
AA761206 germinal center B cell .q 2654 to 2973 320 to 1       320/320
(100 %)
0 diff
(100 %id)
DB132997 thymus .r 1 to 531 7 to 537 E43G tiling clone, capped   536/536
(100 %)
13 diff
(97.6 %id)
DA534148 brain .s 1 to 548 2 to 549 exact tiling clone, capped   548/554
(98 %)
2 diff
(99.7 %id)
DA073031 cerebellum .t 1 to 564 2 to 565   tiling clone, capped   564/565
(99 %)
2 diff
(99.7 %id)
DA367472 subthalamic nucleus .t 40 to 612 2 to 575 C54* tiling clone, capped   574/574
(100 %)
3 diff
(99.5 %id)
BM788748 stomach .u 1 to 646 1 to 649 E73N L74E N75L Q76N C77Q ... tiling clone,   649/649
(100 %)
1 diff
(99.9 %id)
DA039483 bladder .va 1 to 579 3 to 581 exact tiling clone, capped   580/580
(100 %)
1 diff
(99.9 %id)
DB125698 thymus .vb 1 to 504 2 to 506   tiling clone, capped   505/506
(99 %)
7 diff
(98.7 %id)
DA345710 substantia nigra .vb 5 to 592 2 to 589   capped   588/588
(100 %)
0 diff
(100 %id)
DA513295 brain .vb 5 to 584 2 to 581   capped   580/580
(100 %)
2 diff
(99.7 %id)
DB112383 thymus .vb 42 to 531 2 to 491   capped   490/490
(100 %)
2 diff
(99.6 %id)
AW409714.
matches multiple genes
muscle, rhabdomyosarcoma .vb 51 to 726 20 to 698     Possibly primed on the genome, locally A rich (23/25 A in genome downstream of last aligned base), also hits gene GPR141andTXNDC3andEPDR1 679/698
(97 %)
7 diff
(99.0 %id)
BC064985 Muscle, rhabdomyosarcoma .vb 51 to 2087 1 to 2040 K177R K388E tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (25/27 A in genome downstream of last aligned base) 2040/2040
(100 %)
4 diff
(99.9 %id)
BE294300 muscle, rhabdomyosarcoma .vb 70 to 664 1 to 596   available from MGC,   596/790
(75 %)
6 diff
(99.3 %id)
BE294154 muscle, rhabdomyosarcoma .vb 70 to 548 1 to 479       479/480
(99 %)
1 diff
(99.8 %id)
BE269861 Burkitt lymphoma, lymph .vb 70 to 753 1 to 684       684/686
(99 %)
10 diff
(98.6 %id)
BF695906 brain, primitive neuroectoderm .vc 1 to 680 1 to 668 F16L E17* tiling clone,   668/886
(75 %)
43 diff
(95.2 %id)
BU944550 adenocarcinoma, cell line, breast .vc 207 to 1087 888 to 6   tiling clone, Submitted on the opposite strand 883/914
(96 %)
1 diff
(99.9 %id)
BM470736 leiomyosarcoma, uterus .vc 548 to 1085 1 to 538   AAA Possibly primed on the genome, locally A rich (19/19 A in genome downstream of last aligned base) 538/538
(100 %)
6 diff
(98.9 %id)
BE161336 head_neck .vc 595 to 1008 1 to 414   tiling clone,   414/414
(100 %)
3 diff
(99.3 %id)
DB084853 testis .vd 1 to 573 2 to 574   tiling clone, capped   573/573
(100 %)
0 diff
(100 %id)
DA480585   .vd 52 to 569 2 to 519   capped   518/518
(100 %)
1 diff
(99.9 %id)
DA751194   .vd 53 to 614 2 to 563   tiling clone, capped   562/562
(100 %)
1 diff
(99.9 %id)
DA753148   .vd 56 to 600 8 to 552   capped   545/545
(100 %)
1 diff
(99.9 %id)
DA779625 brain .ve 1 to 573 2 to 577 exact tiling clone, capped   576/576
(100 %)
1 diff
(99.9 %id)
AI081603 liver and spleen .vf-u 1 to 376 376 to 1 exact tiling clone,   376/376
(100 %)
0 diff
(100 %id)
AL710232 human skeletal muscle Gene ZNF430andZNF714, variant not shown         Suspected internal deletion, this clone was ignored    
AV747509 Pituitary Gene ZNF430andZNF714, variant not shown         Suspected internal deletion, this clone was ignored    
DB151092 thymus Gene ZNF430andZNF714, variant not shown       capped This clone was ignored    
DB346136 thymus Gene ZNF430andZNF714, variant not shown         This clone was ignored    
DB265481 uterus Gene ZNF430andZNF714, variant not shown       capped Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f-u, .g, .h, .i, .j, .k-u, .l, .m, .n, .o, .p, .q, .r, .s, .t, .u, .va, .vb, .vc, .vd, .ve, .vf-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes C